<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">27647063</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>12</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-2607</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>51</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2016</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>American journal of preventive medicine</Title>
<ISOAbbreviation>Am J Prev Med</ISOAbbreviation>
</Journal>
<ArticleTitle>CHARTing a Path to Pragmatic Tobacco Treatment Research.</ArticleTitle>
<Pagination>
<MedlinePgn>630-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amepre.2016.05.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0749-3797(16)30238-0</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION">It is important to consider the degree to which studies are explanatory versus pragmatic to understand the implications of their findings for patients, healthcare professionals, and policymakers. Pragmatic trials test the effectiveness of interventions in real-world conditions; explanatory trials test for efficacy under ideal conditions. The Consortium of Hospitals Advancing Research on Tobacco (CHART) is a network of seven NIH-funded trials designed to identify effective programs that can be widely implemented in routine clinical practice.</AbstractText>
<AbstractText Label="METHODS">A cross-sectional analysis of CHART trial study designs was conducted to place each study on the pragmatic-explanatory continuum. After reliability training, six raters independently scored each CHART study according to ten PRagmatic Explanatory Continuum Indicator Summary (PRECIS) dimensions, which covered participant eligibility criteria, intervention flexibility, practitioner expertise, follow-up procedures, participant compliance, practitioner adherence, and outcome analyses. Means and SDs were calculated for each dimension of each study, with lower scores representing more pragmatic elements. Results were plotted on "spoke and wheel" diagrams. The rating process and analyses were performed in October 2014 to September 2015.</AbstractText>
<AbstractText Label="RESULTS">All seven CHART trials tended toward the pragmatic end of the spectrum, although there was a range from 0.76 (SD=0.23) to 1.85 (SD=0.58). Most studies included some explanatory design elements.</AbstractText>
<AbstractText Label="CONCLUSIONS">CHART findings should be relatively applicable to clinical practice. Funders and reviewers could integrate PRECIS criteria into their guidelines to better facilitate pragmatic research. CHART study protocols, coupled with scores reported here, may help readers improve the design of their own pragmatic trials.</AbstractText>
<CopyrightInformation>Copyright Â© 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cruvinel</LastName>
<ForeName>Erica</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address: ecruvinel@yahoo.com.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richter</LastName>
<ForeName>Kimber P</ForeName>
<Initials>KP</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Medicine and Public Health and The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stoney</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duffy</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Ohio State University, Columbus, Ohio; Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fellows</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Kaiser Permanente Center for Health Research, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harrington</LastName>
<ForeName>Kathleen F</ForeName>
<Initials>KF</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rigotti</LastName>
<ForeName>Nancy A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine and Tobacco Research and Treatment Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sherman</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departments of Population Health, Medicine and Psychiatry; New York University School of Medicine, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tindle</LastName>
<ForeName>Hilary A</ForeName>
<Initials>HA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shireman</LastName>
<ForeName>Theresa I</ForeName>
<Initials>TI</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Services, Policy, and Practice, Brown University, Providence, Rhode Island.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shelley</LastName>
<ForeName>Donna</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Population Health, New York University School of Medicine, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Waiwaiole</LastName>
<ForeName>Lisa</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Kaiser Permanente Center for Health Research, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cummins</LastName>
<ForeName>Sharon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Family Medicine and Public Health, University of California, San Diego, California.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U01 HL105232</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Am J Prev Med</MedlineTA>
<NlmUniqueID>8704773</NlmUniqueID>
<ISSNLinking>0749-3797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006761">Hospitals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D064792">Pragmatic Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012107">Research Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020340">Tobacco Use Cessation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>02</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>05</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>05</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>12</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27647063</ArticleId>
<ArticleId IdType="pii">S0749-3797(16)30238-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.amepre.2016.05.025</ArticleId>
<ArticleId IdType="pmc">PMC5919279</ArticleId>
<ArticleId IdType="mid">NIHMS864964</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Trials. 2016 Jan 16;17 :32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26772801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Serv Res. 2012 Jun;47(3 Pt 1):1051-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22092292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:125</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22852834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Epidemiol. 2009 May;62(5):464-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19348971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:126</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22852878</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:123</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22852802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2005 Jan 1-7;365(9453):82-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15639683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22852832</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:122</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22852768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Epidemiol. 2009 May;62(5):489-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19348974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:127</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22853047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2015 May 08;350:h2147</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25956159</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med Res Methodol. 2012 Jul 23;12:101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22824225</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2009 May 12;180(10):1001-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19372437</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Epidemiol. 2009 May;62(5):485-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19348973</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:128</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22853197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2012 Aug 01;13:129</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22853325</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>